Search PubMedSearch

PubMed · 2515784

[Long term depression].

Abstract

Our practice, in a unit of treatment of dysthymic state being confronted with problems of relapses and recurrences, we have questioned the therapeutic strategies in the long run and their possible assessments. After recalling conceptual and methodological reference about relapses, recurrences and therapeutic assessment, we propose the methods and first results of a retrospective naturalistic study over a period of three years of practice in our treatment unit including 994 cases. We bring out, as soon as the first major depressive episode occurs, a strategy that aims at setting up a therapeutic proceeding tending to treat, beyond the dysthymic episode, the obsessional pre and post-morbid "locks" which seem to "make the bed" of many relapses and recurrences. In this prospect, the interest of serotoninergic molecules with double polarity, anti-depressive and anti-compulsive, is emphasized.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Y Prigent. 1989. [Long term depression].. https://pubmed.ncbi.nlm.nih.gov/2515784/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities.

The average daily dose and need for dose escalations for the drugs known as selective serotonin reuptake inhibitors (SSRIs) has frequently been a point of controversy. This study reports on the information gathered from nine Veterans Affairs hospitals over a two six-month periods. Average daily doses of fluoxetine, paroxetine, and sertraline started at 30.9 mg, 24.2 mg, and 87.8 mg and ended at 28.4 mg, 24.2 mg, and 89.8 mg, respectively. Cost, number of prescriptions, and dosage strength data is also presented.

Depressive Disorder